Page last updated: 2024-11-06

4-ethylguaiacol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-Ethylguaiacol is an organic compound with the molecular formula C10H12O2. It is a colorless liquid with a strong, pungent odor. 4-Ethylguaiacol is found naturally in wood smoke and is a major contributor to the smoky flavor of smoked foods. It is also used as a flavoring agent in the food industry. 4-Ethylguaiacol is a potent antioxidant and has been shown to have a number of beneficial health effects, including anti-inflammatory and anti-cancer properties. It is also a key component of the scent of vanilla. The compound has been studied for its potential as a flavor enhancer and as a therapeutic agent. Its synthesis involves the reaction of guaiacol with ethyl bromide in the presence of a base. '

4-ethylguaiacol: a constituent of wood creosote; suppresses intestinal smooth muscle contraction [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID62465
CHEMBL ID3186900
CHEBI ID179252
SCHEMBL ID109504
MeSH IDM0225737

Synonyms (67)

Synonym
AC-15463
CHEBI:179252
4-hydroxy-3-methoxy ethylbenzene
4-ethylguaiacol
nsc-82313
nsc82313
4-ethyl-2-methoxyphenol
2785-89-9
p-ethylguaiacol
2-methoxy-4-ethylphenol
phenol, 4-ethyl-2-methoxy-
inchi=1/c9h12o2/c1-3-7-4-5-8(10)9(6-7)11-2/h4-6,10h,3h2,1-2h
4-ethylguaiacol, >=98%, fcc, fg
E0353
2-phenyl-pyrazolo[1,5-a]pyrimidin-5-ol
bx3thx8lt4 ,
unii-bx3thx8lt4
dtxsid0047038 ,
dtxcid8027038
cas-2785-89-9
tox21_302308
NCGC00256287-01
homocresol
einecs 220-500-4
fema no. 2436
guaiacyl ethane
guaiacol, 4-ethyl-
c9nfd83bj5 ,
nsc 82313
4-hydroxy-3-methoxyphenylethane
unii-c9nfd83bj5
1-hydroxy-2-methoxy-4-ethylbenzene
4-hydroxy-3-methoxyethylbenzene
FT-0618412
AKOS015851764
SCHEMBL109504
4-ethyl-2-methoxy phenol
4-ethyl-2-methoxy-phenol
4-ethyl guaiacol
4-ethylguaiacol [fhfi]
4-ethyl guaiacol [fcc]
phenol, 2-methoxy-4-ethyl
guaiacol, 4-ethyl
4-ethyl-2-methoxyphenol (4-ethylguaiacol)
p-ethyl-2-methoxyphenol
4-ethyl-2-metoxy phenol
Q-100353
CHEMBL3186900 ,
mfcd00038714
4-ethylguaiacol, analytical standard
4-ethylguaiacol, natural, fg
ethylguiacol (4-ethyl-2-methoxyphenol)
fema 2436
4-ethyl-guaiacol
4-ethyl guiacol
DS-4664
BCP19091
4-ethyl-d5-2-methoxyphenol
Q229953
CCG-356437
D90493
4-ethylguaiacol 1000 microg/ml in methanol
bdbm50548721
CS-W018090
SY001597
EN300-120486
Z57234301
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
methoxybenzenesAny aromatic ether that consists of a benzene skeleton substituted with one or more methoxy groups.
phenolsOrganic aromatic compounds having one or more hydroxy groups attached to a benzene or other arene ring.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (2)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
estrogen nuclear receptor alphaHomo sapiens (human)Potency68.58960.000229.305416,493.5996AID743079
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Transient receptor potential cation channel subfamily A member 1Homo sapiens (human)EC50 (µMol)101.00000.00033.166210.0000AID1682372
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (17)

Processvia Protein(s)Taxonomy
monoatomic ion transportTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
intracellular calcium ion homeostasisTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
cell surface receptor signaling pathwayTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to coldTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to xenobiotic stimulusTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to organic substanceTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to organic cyclic compoundTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
sensory perception of painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
calcium-mediated signalingTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
thermoceptionTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
detection of mechanical stimulus involved in sensory perception of painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
detection of chemical stimulus involved in sensory perception of painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
protein homotetramerizationTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
cellular response to hydrogen peroxideTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
calcium ion transmembrane transportTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
cellular response to organic substanceTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (5)

Processvia Protein(s)Taxonomy
calcium channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
intracellularly gated calcium channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
identical protein bindingTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
temperature-gated cation channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (2)

Processvia Protein(s)Taxonomy
plasma membraneTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
stereocilium bundleTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1682372Agonist activity at TRPA1 (unknown origin) by calcium imaging assay2021Bioorganic & medicinal chemistry letters, 01-01, Volume: 31Discovery of natural TRPA1 activators through pharmacophore-based virtual screening and a biological assay.
AID1682371Agonist activity at TRPA1 (unknown origin) by calcium imaging assay relative to allyl isothiocyanate2021Bioorganic & medicinal chemistry letters, 01-01, Volume: 31Discovery of natural TRPA1 activators through pharmacophore-based virtual screening and a biological assay.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (46)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (2.17)18.2507
2000's14 (30.43)29.6817
2010's24 (52.17)24.3611
2020's7 (15.22)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 36.13

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index36.13 (24.57)
Research Supply Index3.87 (2.92)
Research Growth Index5.13 (4.65)
Search Engine Demand Index45.27 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (36.13)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.13%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other46 (97.87%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]